Sofosbuvir/velpatasvir granted orphan status in the U.S. for pediatric hepatitis C virus infection Feb. 24, 2017
Bavarian Nordic reports 6-month follow-up data from phase I study of RSV vaccine candidate Feb. 24, 2017